Major adverse cardiac events
Showing 26 - 50 of >10,000
Adverse Events in Pediatric Cardiac Surgery
Completed
- Congenital Heart Disease in Children
- +2 more
- Fluid balance
-
Brussels, BelgiumHôpital Universitaire des Enfants Reine Fabiola
Jul 19, 2022
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Obstructive Hypertrophic Cardiomyopathy
Completed
- Microvascular Dysfunction
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, China National Center for Cardiovascular Disease
Jan 11, 2023
STEMI Trial (PPCI in heavy thrombus burden STEMI patients)
Not yet recruiting
- STEMI
- PPCI in heavy thrombus burden STEMI patients
- (no location specified)
Mar 30, 2023
Vascular Events In Patients Undergoing Same-day Noncardiac
Recruiting
- Preoperative Care
- +2 more
-
Montreal, Quebec, Canada
- +1 more
Jul 28, 2022
Cardiovascular Diseases Trial in Peking (cardiovascular magnetic resonance (CMR))
Completed
- Cardiovascular Diseases
- cardiovascular magnetic resonance (CMR)
-
Peking, Beijing, ChinaChinese PLA General Hospital
Apr 3, 2022
In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)
Recruiting
- In-stent Restenosis
- Major Adverse Cardiovascular Events
- PCSK9 inhibitor
- Statin
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital
Jan 16, 2023
Major Adverse Cardiovascular Events for Naldemedine and Other
Recruiting
- Opioid-induced Constipation
- Naldemedine
- +2 more
-
Wilmington, DelawareResearch Site
Feb 28, 2022
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Peripheral Arterial Disease Trial in Fribourg, Zurich (sirolimus-coated balloon catheter, uncoated balloon catheter)
Recruiting
- Peripheral Arterial Disease
- sirolimus-coated balloon catheter
- uncoated balloon catheter
-
Fribourg, Switzerland
- +1 more
Mar 4, 2022
MACE and PE in Elective Primary TKA & THA
Completed
- Cardiovascular Complication
- +4 more
-
Larissa, GreeceUniversity of Thessaly
Oct 29, 2021
Cancer, Drug Toxicity, Atrial Fibrillation Trial in Caen (occurence of atrial fibrillation)
Recruiting
- Cancer
- +3 more
- occurence of atrial fibrillation
-
Caen, Normandy, FranceAlexandre
Jul 6, 2022
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Low-density Lipoprotein Cholesterol Reduction With
Recruiting
- Acute Coronary Syndrome
- Dyslipidemias
-
Banja Luka, Republic Of Srpska, Bosnia and HerzegovinaUniversity Clinical Centre of the Republic of Srpska
Oct 17, 2021
Characterization of Arrhythmia-induced Cardiomyopathy
Recruiting
- Cardiomyopathy
- Arrhythmia-induced Cardiomyopathy (AiCM)
- Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)
- +3 more
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Cardiology
Jan 2, 2023
Risk Factors for Predictors of MACEs After RA-CABG
Completed
- Coronary Artery Disease
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 30, 2021
Effect of CVP and IOH on AKI and AKD
Completed
- Acute Kidney Injury
- Acute Kidney Disease
- Venous congestion
- Introperation hypotension
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Jan 23, 2022
Atrial Fibrillation and Flutter, Atrial Fibrillation, Postoperative Complications Trial in Leuven (Photoplethysmography based
Recruiting
- Atrial Fibrillation and Flutter
- +3 more
- Photoplethysmography based smartphone application for heart rhythm analysis (FibriCheck™)
-
Leuven, BelgiumUniversity Hospitals Leuven
Aug 16, 2022
Coronary Artery Disease Trial in Isparta (N-acetyl cysteine, Saline)
Active, not recruiting
- Coronary Artery Disease
- N-acetyl cysteine
- Saline
-
Isparta, Mediterranean Region, TurkeySuleyman Demirel University
Jan 8, 2022
MACCE According to Time Interval of Taking Medication in Acute
Completed
- Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
- Esomezol Cap
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Aug 2, 2022
Acute Coronary Syndrome, Brief Supportive Psychotherapy, Intensive Cardiac Care Unit Trial in Jakarta Pusat (Intervention group)
Completed
- Acute Coronary Syndrome
- +2 more
- Intervention group
-
Jakarta Pusat, DKI Jakarta, IndonesiaMedical Faculty
Feb 18, 2020
PARA-HEART Pilot Implementation
Completed
- Acute Coronary Syndrome
- Chest Pain
-
Winston-Salem, North CarolinaWake Forest School Of Medicine
Mar 3, 2022
Adverse Events After Cardiac Surgery
Recruiting
- Heart; Dysfunction Postoperative, Cardiac Surgery
- +4 more
-
Boston, Massachusetts
- +2 more
May 7, 2021